GlassScriptPhysician profile
Rihua Chen
NPI 1659013431
$3,051.40
in general payments reported to CMS, 2019-2025
8 companies · $1,624 in 2025
The $1,624 reported for 2025 was more than what 80% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.41 · 2023: $314 · 2024: $1,093 · 2025: $1,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,476 · Travel and Lodging: $555.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,475.60 |
| Travel and Lodging | $555.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,157.25 | 2023-2025 | Stravix Pl, Grafix Pl, Oasis |
| Treace Medical Concepts, INC. | $656.69 | 2025 | |
| Organogenesis INC. | $447.41 | 2025 | Simplimax, Puraply Wound Matrix |
| Stryker Corporation | $440.23 | 2022-2025 | Citrefix, Ortholoc 2 Lapifuse, Salvation |
| Convatec INC. | $146.69 | 2023 | |
| Abbvie INC. | $118.02 | 2024 | |
| Paladin Technology Solutions | $64.32 | 2023-2025 | |
| Mimedx Group, INC. | $20.79 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rihua Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.